Alto Neuroscience Inc (ANRO) Annual Balance Sheets

Annual · GAAP · USD millions
Access ANRO quarterly Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Alto Neuroscience Inc manages assets, liabilities, and equity through different cycles.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024)
Assets
Cash & cash equivalent176.48
Cash & Short-term Investments176.00
Prepaid Expense And Other Assets Current1.23
Total Current Assets177.72
Equipment/Property/Plant Net1.87
Other Assets, Noncurrent5.10
Restricted Cash Noncurrent0.50
Total Assets184.69
Liabilities
Accounts Payable, Current AC1.88
Accrued Liabilities, Current AC8.86
Long-term Debt, Current Maturities LO0.59
Total Current Liabilities11.33
Long-term debt16.17
Convertible Debt LO2.23
Total Long-term Debt18.40
Other liabilities, Noncurrent3.82
Total Liabilities33.55
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock352.75
Retained Earnings / Accumulated Deficit-201.63
Other Equity0.02
Common Stockholder's Equity151.14
Total Stockholder's Equity151.14
Liabilities & Stockholder's Equity184.69
4 historic quarters locked

Sign in to unlock the full Alto Neuroscience Inc balance sheet history.

About Alto Neuroscience Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001999480-26-000002

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.